Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Naji Bou Zeid & Victor Yazbeck. (2023) PI3k Inhibitors in NHL and CLL: An Unfulfilled Promise. Blood and Lymphatic Cancer: Targets and Therapy 13, pages 1-12.
Read now
Read now
Lu Zhou, Jinfeng Lu, Zenghua Lin, Xinfeng Wang, Lan Luo, Chenhui Wang, Lemin Hong, Ruirong Xu & Hongmin Huang. (2023) POEMS syndrome: origination from clonal plasma cells or B cells?. Hematology 28:1.
Read now
Read now
Jingbo Zhang, Yiwei Guo, Huiying Fang, Xiuchen Guo & Lina Zhao. (2023) Oncolytic virus oHSV2 combined with PD-1/PD-L1 inhibitors exert antitumor activity by mediating CD4 + T and CD8 + T cell infiltration in the lymphoma tumor microenvironment. Autoimmunity 56:1.
Read now
Read now
Articles from other publishers (37)
Xiaosheng Li, Qianjie Xu, Cuie Gao, Zailin Yang, Jieping Li, Anlong Sun, Ying Wang & Haike Lei. (2023) Development and validation of nomogram prognostic model for predicting OS in patients with diffuse large B-cell lymphoma: a cohort study in China. Annals of Hematology 102:12, pages 3465-3475.
Crossref
Crossref
Firuza М. Abbasbeyli, Alexandr A. Fedenko, Pervin A. Zeynalova, Тatyana Y. Mushkarina, Anzhelika A. Melnikova & Lyudmila Y. Grivtsova. (2023) Identification of Reed-Berezovsky-Sternberg cells in lymphatic nodes in classic Hodgkin's lymphoma by flow cytometry: a clinical case series. Almanac of Clinical Medicine 51:2, pages 134-142.
Crossref
Crossref
Isaac Ellison, Nicholas Callahan & Sarah Moles. (2023) A firm mass at the angle of the mandible. The Journal of the American Dental Association.
Crossref
Crossref
Zhen Jin, Rufang Xiang, Jianmin Dai, Yefei Wang & Zizhen Xu. (2023) HIF‐1α mediates CXCR4 transcription to activate the AKT/mTOR signaling pathway and augment the viability and migration of activated B cell‐like diffuse large B‐cell lymphoma cells. Molecular Carcinogenesis 62:5, pages 676-684.
Crossref
Crossref
Amal F. Alshammary, Mashael Al-Toub, Maha F. Almutairi, Mohammed Bakar, Haifa F. Alshammary, Arwa F.Q. B. Alanazi, Amani F.Q. B. Alanazi, Norah A. Alturki, Haifa Alhawas & Asma Alanazi. 2023. Molecular Targets and Cancer Therapeutics (Part 2). Molecular Targets and Cancer Therapeutics (Part 2)
1
95
.
Xi-Ya Li, Ji-Chuan Wu, Ping Liu, Zi-Juan Li, Yong Wang, Bing-Yi Chen, Cheng-Long Hu, Ming-Yue Fei, Peng-Cheng Yu, Yi-Lun Jiang, Chun-Hui Xu, Bin-He Chang, Xin-Chi Chen, Li-Juan Zong, Jia-Ying Zhang, Ying Fang, Xiao-Jian Sun, Kai Xue, Li Wang, Shu-Bei Chen, Shi-Yu Jiang, Ai-ling Gui, Ling Yang, Juan J. Gu, Bao-Hua Yu, Qun-ling Zhang & Lan Wang. (2022) Inhibition of USP1 reverses the chemotherapy resistance through destabilization of MAX in the relapsed/refractory B-cell lymphoma. Leukemia 37:1, pages 164-177.
Crossref
Crossref
Srushti Mahajan, Mayur Aalhate, Santosh Kumar Guru & Pankaj Kumar Singh. (2022) Nanomedicine as a magic bullet for combating lymphoma. Journal of Controlled Release 347, pages 211-236.
Crossref
Crossref
Alessandro Laghi, Claudia Lee, Alexander Witkowski, Maylee Hsu, Giovanni Pellacani & Joanna Ludzik. (2022) The role of dermatoscopy and reflectance confocal microscopy in the assessment of relapsing secondary cutaneous follicular B-cell lymphoma. JAAD Case Reports 24, pages 91-93.
Crossref
Crossref
Xiaoqing Liu, Lilan Zheng, Ting Wang, Ying Li, Bingbing Wu, Shujuan Du, Qing Zhu, Caixia Zhu, Yuyan Wang, Rong Zhang, Fang Wei & Qiliang Cai. (2022) A System Based on Novel Parainfluenza Virus PIV5-L for Efficient Gene Delivery of B-Lymphoma Cells. Journal of Virology 96:8.
Crossref
Crossref
Alexander Chan, Jose Victor Scarpa Carniello, Qi Gao, Allison Sigler, Jeeyeon Baik, Mikhail Roshal & Oscar Lin. (2022) Role of Flow Cytometric Immunophenotyping for Classic Hodgkin Lymphoma in Small Biopsy and Cytology Specimens. Archives of Pathology & Laboratory Medicine 146:4, pages 462-468.
Crossref
Crossref
Feng Xu, Ying Liang, Wen-Bin Mo, Xiao-Jing Yan & Rui Zhang. (2022) Concurrent lung adenocarcinoma and bladder diffuse large B-cell lymphoma: a case report and literature review. Journal of International Medical Research 50:2, pages 030006052210816.
Crossref
Crossref
Kamila Duś-Szachniewicz, Katarzyna Gdesz-Birula, Krzysztof Zduniak & Jacek R. Wiśniewski. (2021) Proteomic-Based Analysis of Hypoxia- and Physioxia-Responsive Proteins and Pathways in Diffuse Large B-Cell Lymphoma. Cells 10:8, pages 2025.
Crossref
Crossref
Roberto Cascone, Annalisa Carlucci, Gaetana Messina, Antonio Noro, Mary Bove, Giovanni Natale, Caterina Sagnelli, Giorgia Opromolla, Mario Martone, Carlo Santoriello, Elena Santoriello, Pasquale Verolino, Massimiliano Creta, Giovanni Vicidomini, Alfonso Fiorelli, Mario Santini & Antonello Sica. (2021) Ultrasound-Guided Anterior Mediastinotomy: A Feasible Tool for Critical Lymphoma Patients. Healthcare 9:6, pages 770.
Crossref
Crossref
Xiaoqiong Wang, Verity Johnson, Laura Johnson & James R. Cook. (2021) RNA-Based next generation sequencing complements but does not replace fluorescence in situ hybridization studies for the classification of aggressive B-Cell lymphomas. Cancer Genetics 252-253, pages 43-47.
Crossref
Crossref
Chen Tian, Yueyang Li, Su Liu, Zehui Chen, Yizhuo Zhang, Yong Yu, Hongliang Yang, Haifeng Zhao, Zhigang Zhao, Tian Yuan & Yafei Wang. (2021) Modified conditioning regimen with idarubicin followed by autologous hematopoietic stem cell transplantation for invasive B-cell non-Hodgkin’s lymphoma patients. Scientific Reports 11:1.
Crossref
Crossref
Yu Zhang, Jingjing Xiang, Ni Zhu, Hangping Ge, Xianfu Sheng, Shu Deng, Junfa Chen, Lihong Yu, Yan Zhou & Jianping Shen. (2021) The Combination of Jiedu Xiaoluo Decoction with Autologous Peripheral Blood Stem Cell Transplantation (APBSCT) Accelerates Disease Remission of Non-Hodgkin Lymphoma. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-15.
Crossref
Crossref
Tingting Lu & Guoren Yang. (2021) 18F-FDG PET/CT imaging in the diagnosis of drug-induced lung disease and pulmonary infection in lymphoma. Medicine 100:37, pages e27107.
Crossref
Crossref
Antonella CampanaleAlessandra SpagnoliLucia LispiRosaria BoldriniMarcella Marletta. (2020) The Crucial Role of Surgical Treatment in BIA-ALCL Prognosis in Early- and Advanced-Stage Patients. Plastic & Reconstructive Surgery 146:5, pages 530e-538e.
Crossref
Crossref
Xingxing Yu, Xin Wang, Xu Wang, Yi Zhou, Yanchun Li, Aiwei Wang, Tongtong Wang, Yihan An, Weidong Sun, Jing Du, Xiangmin Tong & Ying Wang. (2020) TEOA Inhibits Proliferation and Induces DNA Damage of Diffuse Large B-Cell Lymphoma Cells Through Activation of the ROS-Dependent p38 MAPK Signaling Pathway. Frontiers in Pharmacology 11.
Crossref
Crossref
Ganesh WarthiPierre-Edouard FournierHervé Seligmann. (2020) Identification of Noncanonical Transcripts Produced by Systematic Nucleotide Exchanges in HIV-Associated Centroblastic Lymphoma. DNA and Cell Biology 39:8, pages 1444-1448.
Crossref
Crossref
Nada Assaf, Samer Nassif, Hani Tamim, Ali Bazarbachi, Ghazi Zaatari & Zaher Chakhachiro. (2020) Diagnosing Lymphoproliferative Disorders Using Core Needle Biopsy Versus Surgical Excisional Biopsy: Three-Year Experience of a Reference Center in Lebanon. Clinical Lymphoma Myeloma and Leukemia 20:8, pages e455-e460.
Crossref
Crossref
Amineh Ghaderi, Amir Hossein Daneshmanesh, Ali Moshfegh, Parviz Kokhaei, Jan Vågberg, Johan Schultz, Thomas Olin, Sara Harrysson, Karin E Smedby, Elias Drakos, Georgios Z. Rassidakis, Anders Österborg, Håkan Mellstedt & Mohammad Hojjat-Farsangi. (2020) ROR1 is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells. Biomedicines 8:6, pages 170.
Crossref
Crossref
Eun-Ho Kim, Hae Young Ko, A Ram Yu, Hyeongi Kim, Javeria Zaheer, Hyun Ji Kang, Young-Cheol Lim, Kyung Deuk Cho, Hyun-Yoo Joo, Min Kyoung Kang, Jae Jun Lee, Seung-Sook Lee, Hye Jin Kang, Sang Moo Lim & Jin Su Kim. (2020) Inhibition of HIF-1α by Atorvastatin During 131I-RTX Therapy in Burkitt’s Lymphoma Model. Cancers 12:5, pages 1203.
Crossref
Crossref
Raffaele Nardone, Luca Carnicelli, Francesco Brigo, Slaven Pikija, Larissa Hauer & Johann Sellner. (2020) Cerebral HSV-1 Vasculitis as a Fatal Complication of Immunosuppression in Non-Hodgkin´s Lymphoma: A Case Report and Review of the Literature. Pathogens 9:3, pages 193.
Crossref
Crossref
Ji-cheng Zhou, Mei-qing Wu, Zheng-mian Peng, Wei-hua Zhao & Zhen-jie Bai. (2020) Clinical analysis of 20 patients with non-Hodgkin lymphoma and autoimmune hemolytic anemia. Medicine 99:7, pages e19015.
Crossref
Crossref
Xaver U. Kahle, Menno Hovingh, Walter Noordzij, Annika Seitz, Arjan Diepstra, Lydia Visser, Anke van den Berg, Tom van Meerten, Gerwin Huls, Ronald Boellaard, Thomas C. Kwee & Marcel Nijland. (2019) Tumour necrosis as assessed with 18F-FDG PET is a potential prognostic marker in diffuse large B cell lymphoma independent of MYC rearrangements. European Radiology 29:11, pages 6018-6028.
Crossref
Crossref
Ziang Pan, Meizhu Zheng, Ziyu Qi, Xueqin Li, Jinxin Liu, Yuxin Shi, Xing Wang, Li Li, Wen Ye, Tianli Hu, Shuang Xia & Hongjun Li. (2019) The comparison of clinical and imaging characteristics between AIDS-related diffuse large B-cell lymphoma and Burkitt's lymphoma. Radiology of Infectious Diseases 6:3, pages 100-107.
Crossref
Crossref
Stefania Crisci, Raffaele Di Francia, Sara Mele, Pasquale Vitale, Giuseppina Ronga, Rosaria De Filippi, Massimiliano Berretta, Paola Rossi & Antonio Pinto. (2019) Overview of Targeted Drugs for Mature B-Cell Non-hodgkin Lymphomas. Frontiers in Oncology 9.
Crossref
Crossref
Ravnit‐Kaur Grewal, Manogari Chetty, Emmanuel‐Akinola Abayomi, Ciprian Tomuleasa & Jonathan R. Fromm. (2018) Use of flow cytometry in the phenotypic diagnosis of hodgkin's lymphoma. Cytometry Part B: Clinical Cytometry 96:2, pages 116-127.
Crossref
Crossref
Wojciech Jurczak, Monika Długosz-Danecka & Fernando Rivas Navarro. (2019) The rationale for combination therapy in patients with aggressive B-cell non-Hodgkin lymphoma: ten questions. Future Oncology 15:3, pages 305-317.
Crossref
Crossref
Chad M. McCall, Adam L. Booth & Nicole D. Riddle. 2019. Practical Head and Neck Pathology. Practical Head and Neck Pathology
277
329
.
Andrea Di Pietro & Kim L. Good-Jacobson. (2018) Disrupting the Code: Epigenetic Dysregulation of Lymphocyte Function during Infectious Disease and Lymphoma Development. The Journal of Immunology 201:4, pages 1109-1118.
Crossref
Crossref
Junichi Miyatake, Hiroaki Inoue, Kentarou Serizawa, Yasuyoshi Morita, JL Espinoza, Hirokazu Tanaka, Takahiro Shimada, Yoichi Tatsumi, Takashi Ashida & Itaru Matsumura. (2018) Synchronous Occurrence of Mycosis Fungoides, Diffuse Large B Cell Lymphoma and Acute Myeloid Leukemia. Internal Medicine 57:10, pages 1445-1453.
Crossref
Crossref
Haixiao Zou, Haili Yang, Yuan Zou, Lang Lei & Li Song. (2018) Primary diffuse large B-cell lymphoma in the maxilla. Medicine 97:20, pages e10707.
Crossref
Crossref
Xiao Yan, Yile Zhou, Shujuan Huang, Xia Li, Mengxia Yu, Jiansong Huang, Jinghan Wang, Zhixin Ma, Jingrui Jin, Jiajia Pan, Chenying Li, Fenglin Li & Jie Jin. (2018) Promising efficacy of novel BTK inhibitor AC0010 in mantle cell lymphoma. Journal of Cancer Research and Clinical Oncology 144:4, pages 697-706.
Crossref
Crossref
Ting Zhou, Qian Shen, Hui Peng, Tengfei Chao, Lihong Zhang, Liu Huang, Kaixiang Yang, Sudip Thapa, Shiying Yu & Yongsheng Jiang. (2017) Incidence of interstitial pneumonitis in non-Hodgkin’s lymphoma patients receiving immunochemotherapy with pegylated liposomal doxorubicin and rituximab. Annals of Hematology 97:1, pages 141-147.
Crossref
Crossref
Jin Li, Changgeng Qian, Qianqian Zhou, Jiwei Li, Kunlun Li & Pingyong Yi. (2017) RETRACTED: BEBT-908: A novel potent PI3K/HDAC inhibitor against diffuse large B-cell lymphoma. Biochemical and Biophysical Research Communications 491:4, pages 939-945.
Crossref
Crossref